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INT ROD UCT ION
NF-κB proteins comprise a family of transcription factors 
that can interact to form homo- and heterodimers with dis-
tinct regulatory functions (Sun et al., 2013). In unstimulated 
cells, inactive NF-κB dimers are sequestered in the cytosol by 
a family of inhibitory proteins called IκBs (Sun et al., 2013). 
After stimulation, phosphorylation of IκB inhibitors by the 
IκB kinase (IKK) complex results in their polyubiquitination 
and degradation, with concomitant translocation of active 
NF-κB to the nucleus. In T cells, NF-κB activation is induced 
after stimulation of the TCR and involves recruitment and 
assembly of the Carma1–Bcl10–MALT1 (CBM) complex 
(Rawlings et al., 2006), with the subsequent phosphoryla-
tion and degradation of IκB inhibitors (Schulze-Luehrmann 
and Ghosh, 2006). Ubiquitination of CBM complex proteins 
such as MALT1 and Bcl10 promotes association with regu-
latory components of the IKK complex (Oeckinghaus et al., 
2007; Wu and Ashwell, 2008), thereby linking ubiquitination 
of the CBM complex to recruitment of IKKs and activa-
tion of NF-κB in T cells.
In this context, enzymes that disassemble ubiquitin 
chains from protein substrates have been shown to func-
tion as negative regulators of the NF-κB signaling pathway 
(Harhaj and Dixit, 2012). The zinc finger protein A20, also 
known as TNF-induced protein 3 (TNF AIP3), is character-
ized as a deubiquitinating enzyme (DUB) capable of nega-
tively regulating activation of NF-κB in T cells (Coornaert 
et al., 2008; Stilo et al., 2008). Here, constitutive A20 DUB 
activity removes ubiquitin chains from protein substrates 
such as MALT1, thereby inhibiting inducible IKK activity 
in resting T cells. The rapid removal of A20 after TCR stim-
ulation is therefore associated with elevated IKK activity and 
enhanced NF-κB signaling in activated T cells (Düwel et al., 
2009). Such findings are reflected in a requirement for A20 
during the development, activation, and survival of the CD4 
and CD8 T cell compartments in mice (Giordano et al., 2014; 
Matsuzawa et al., 2015; Onizawa et al., 2015).
Invariant NKT (iNKT) cells are an innate T cell pop-
ulation derived from CD4+ T lineage–committed cells that 
recognize glycolipid antigens presented by the MHC class I–
related molecule CD1d (Bendelac et al., 2007). Positive selec-
tion of iNKT precursors is associated with the initiation of a 
developmental program marked by the differential expression 
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of CD24, CD44, and NK1.1 (Bendelac et al., 2007), which 
define sequential stages of maturation in the thymus and pe-
ripheral organs of mice. Inhibition of NF-κB in thymocytes 
arrests the development of iNKT cell precursors before the 
NK1.1+ stage (Stanic et al., 2004), presumably reflecting a 
threshold requirement for NF-κB activity during the earli-
est stages of iNKT cell differentiation. In contrast, NF-κB 
proteins, such as p50 (NF-κB1) and p65 (RelA), regulate 
maturation of the iNKT cell lineage (Sivakumar et al., 2003; 
Stankovic et al., 2011), and are proposed to have redundant 
functions during the initial stages of iNKT cell development. 
Interestingly, regulation of constitutive NF-κB activation by 
the deubiquitinase cylindromatosis (CYLD) controls iNKT 
cell maturation and hyperactivation in a manner dependent 
on ICOS expression and responsiveness toward the cytokine 
IL-7 (Lee et al., 2010). Whether A20 has a functional role 
during iNKT cell development has yet to be explored. In this 
study, we investigated the role of A20 during iNKT cell de-
velopment and identify A20 as an essential regulator of iNKT 
cell differentiation and function in mice.
RES ULTS AND DIS CUS SION
A20GFP transgenic mice report increased expression of A20 
mRNA within the peripheral iNKT cell compartment
Initial in situ hybridization studies revealed that A20 is con-
stitutively expressed in subpopulations of thymocytes and pe-
ripheral T cells (Tewari et al., 1995; Giordano et al., 2014; 
Matsuzawa et al., 2015; Onizawa et al., 2015); however, it 
is currently unknown whether the iNKT cell lineage dif-
ferentially expresses A20 mRNA in thymus and peripheral 
organs during development. To create a fluorescent reporter 
that would reflect endogenous expression of A20 mRNA in 
iNKT cells, we inserted GFP at the start codon of exon 2 of 
the A20 (tnfaip3) gene in a bacterial artificial chromosome 
(BAC) construct. Two of three C57BL/6J founders gener-
ated expressed identical levels of GFP in CD4+ and CD3ε+ 
thymocytes, respectively (Fig. 1, A and B; and not depicted). 
Flow cytometric analysis of lymphocytes isolated from the 
thymus, spleen, and liver of A20GFP reporters (founder 672) 
revealed differential expression of GFP within distinct T cell 
lineages during development. In thymus, A20GFP median flu-
orescence intensity (MFI) increased as thymocyte precur-
sors matured from stages double-negative (DN) 1 to DN3 
(Fig. 1 C), but was virtually extinguished within DN4 thymo-
cytes. A20GFP was then reexpressed during positive selection 
of double-positive (DP) thymocytes (CD3ε− DP to CD3εhi 
DP; Fig. 1 C), and modestly up-regulated within the CD4 
single-positive (SP), CD8 SP, and γδ T cell lineages during 
maturation. Similarly, developing iNKT thymocytes up-regu-
lated A20GFP mRNA during maturation from immature stage 
1 (CD44−NK1.1−) to mature stage 3 (CD44+NK1.1+) cells 
(Fig. 1 C). In spleen and liver, CD4, CD8, and γδ T cell lin-
eages expressed roughly uniform levels of A20GFP (Fig. 1 D), 
with the highest comparative A20GFP MFI detected within 
splenic iNKT cells. In contrast, A20GFP expression within 
NKT1, 2, and 17 sublineages (Lee et al., 2013; Drennan et 
al., 2014) was comparable in all organs examined (Fig. 1 E), 
with the highest overall expression detected within splenic 
and popliteal LN (PLN) NKT sublineages, respectively. Thus, 
comparative levels of A20GFP are expressed in developing T 
and iNKT thymocytes, and peripheral iNKT cell maturation 
is associated with up-regulation of A20GFP, particularly within 
NKT sublineages present in the spleen and PLNs.
A20 is an essential regulator of iNKT cell development
A20 has recently been shown to regulate NF-κB–dependent 
development and activation of primary CD8 T cells in vivo 
(Giordano et al., 2014), thereby substantiating previous stud-
ies describing a regulatory role for A20 during activation of 
NF-κB in T cells in vitro (Coornaert et al., 2008; Stilo et 
al., 2008; Düwel et al., 2009). To examine the requirement 
for A20 during iNKT cell development, we generated CD4 
T cell–specific, A20-deficient mice by intercrossing CD4-cre 
transgenic mice with mice carrying a LoxP-flanked A20 al-
lele (Vereecke et al., 2010). Here, deletion of A20 DNA and 
protein in splenic CD4 T cells isolated from CD4-cre;A20F/F 
mice was confirmed by Southern and Western blot analy-
sis, respectively (unpublished data). Strikingly, the frequency 
and absolute cell counts of iNKT cells present in the thy-
mus, blood, spleen, liver, lung, and PLNs of CD4-cre;A20F/F 
mice were severely reduced when compared with littermate 
controls (Fig.  2, A and B). A subsequent analysis of iNKT 
cell maturation in thymus of CD4-cre;A20F/F mice using 
cell surface markers CD24, CD44, and NK1.1 (Bendelac 
et al., 2007) revealed similar percentages of stage 0 (CD24hi 
CD44loNK1.1−), stage 1 (CD24−CD44loNK1.1−), stage 2 
(CD24−CD44hiNK1.1−), and stage 3 (CD24−CD44hiNK1.1hi) 
iNKT cells compared with littermate controls (Fig.  2  C); 
however, the absolute number of stage 3 iNKT thymocytes 
detected in CD4-cre;A20F/F thymi was significantly lower 
than that observed in control thymi (Fig. 2 D). These results 
suggest that A20 is not involved in the selection and expan-
sion of iNKT cell precursors, but rather maturation of stage 3 
NK1.1+ iNKT thymocytes. In this context, a previous study 
has shown that maturation of stage 3 iNKT thymocytes is 
unaffected in CYLD-deficient mice (Lee et al., 2010), sug-
gesting that iNKT cell development is differentially regulated 
by CYLD. More recently, an alternate iNKT cell develop-
mental model was proposed in which promyelocytic leuke-
mia zinc finger–positive iNKT cell precursors give rise to 
three distinct iNKT cell sublineages, termed NKT1, NKT2, 
and NKT17 (Lee et al., 2013). NKT1, NKT2, and NKT17 
sublineage cells are characterized by differential expression 
of the transcription factors T-bet, GATA-3, and RORγt and 
produce the cytokines IFN-γ, IL-4, and IL-17, respectively. 
Furthermore, NKT1 sublineage cells can be subdivided into 
two subsets, defined as NKT1a and NKT1b, which exhibit 
distinct developmental and tissue-specific distribution profiles 
(Drennan et al., 2014). An analysis of iNKT cell development 
in CD4-cre;A20F/F mice using the aforementioned alternate 
o
n
 N
ovem
ber 4, 2016
D
ow
nloaded from
 
Published August 22, 2016
1975JEM Vol. 213, No. 10
NKT cell developmental scheme revealed a selective reduc-
tion in NKT1a thymocytes in CD4-cre;A20F/F thymi relative 
to controls (Fig. 2, E and F), with no significant differences 
observed within the NKT1b, NKT2, or NKT17 populations 
in thymus. In contrast, reduced numbers of both NKT1 and 
NKT2 sublineages were detected in the blood, spleen, liver, 
lung, and PLNs of CD4-cre;A20F/F mice relative to controls 
(Fig. 2, E and F), whereas the frequency and distribution of 
NKT17 sublineage cells in all organs examined were no dif-
ferent between control and CD4-cre;A20F/F mice (Fig. 2, E 
and F). Thus, A20 regulates development of NKT1 cells in 
thymus and peripheral NKT1 and NKT2 sublineages but is 
not required for development of the NKT17 sublineage.
A20 regulates activation and survival of 
NKT1 and NKT2 sublineages
Because analysis of A20GFP reporter mice demonstrated that 
A20 is uniformly expressed within NKT sublineages in an 
organ-specific manner (Fig. 1 D), we examined whether A20 
mRNA expression is differentially expressed in in vitro –ex-
panded iNKT cells after stimulation. Here, A20 mRNA was 
significantly up-regulated in bulk splenic iNKT cells stim-
ulated via their TCR, as opposed to iNKTs incubated in 
the presence of various cytokine or TLR-dependent stim-
uli (Fig. 3 A). Furthermore, TCR-dependent stimulation of 
in vitro–expanded NKT cell sublineages resulted in compa-
rable induction of A20 mRNA relative to medium controls 
(Fig.  3  B), mirroring expression of A20 within NKT sub-
lineages in A20GFP reporter mice (Fig.  1  D). A subsequent 
phenotypic analysis of NKT sublineage cells isolated from 
the thymi of CD4-cre;A20F/F mice revealed a significant 
up-regulation of CD69 within NKT1a and NKT2 thymo-
cytes when compared with controls (Fig.  3  C), suggesting 
that A20 functions to restrict expression of this activation 
marker during development. In addition, A20-deficient 
NKT1a thymocytes failed to up-regulate the chemokine re-
ceptor CXCR3 (Fig. 3 D), whereas cell-surface expression 
of ICOS was not affected by deletion of A20 (unpublished 
data), suggesting that A20 and CYLD differentially regulate 
activation of NKT1 and 2 sublineages during development 
(Lee et al., 2010). We next examined whether A20 regulates 
TCR-induced cytokine production by in vitro–expanded 
NKT1 and NKT2 sublineage cells. For these experiments, 
NKT1 and NKT2 thymocytes were FACS sorted from 
control and CD4-cre;A20F/F thymi, expanded in vitro, and 
stimulated with plate-bound anti-CD3ε/CD28 as previously 
described (Govindarajan et al., 2015). As shown in Fig. 3 (E 
and F), A20-deficient NKT1 and NKT2 thymocytes secreted 
significantly higher levels of IL-4, IL-6, and IFN-γ after TCR 
stimulation than did control NKT cells, suggesting that A20 
functions to limit TCR-dependent activation of NKT1 and 2 
sublineages in thymus. Furthermore, up-regulated expression 
of CD69 and enhanced cytokine production by NKT1 and 
2 thymocytes in the absence of A20 was associated with in-
creased activity of intracellular caspase-3 in both thymus and 
spleen (Fig. 3 G), suggesting that A20 regulates activation-in-
duced cell death (AICD) within the NKT1 and 2 compart-
ments. To evaluate whether A20 limits AICD of iNKT cells 
via apoptosis or necroptosis (Onizawa et al., 2015) in vivo, we 
transferred control or A20-deficient thymocytes into irradi-
ated congenic hosts pretreated with either the pan-caspase 
inhibitor Z-VAD-FMK or the necroptosis RIP1 kinase in-
Figure 1. Up-regulated A20 mRNA expression within peripheral iNKT cells in A20GFP reporter mice. A20GFP expression within (A) CD4+ and (B) 
CD3ε+ thymocytes isolated from Founder 672 (open histogram; n = 6) and C57BL/6J (filled histogram, n = 6) mice, respectively. (C and D) A20GFP median 
fluorescence intensity (MFI) within T cell subsets isolated from thymus, spleen, and liver of A20GFP mice (n = 6). (E) A20GFP MFI within NKT sublineages iso-
lated from thymus, blood, spleen, liver, lung, and PLNs of A20GFP mice, respectively (n = 4). All data are from two independent experiments. Numbers in B–D 
represent A20GFP MFI within the indicated subsets. ST, stage; LP, lymphocyte precursor.
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hibitor necrostatin 1 (Onizawa et al., 2015). Analysis of the 
frequency of iNKT cells recovered from chimeras treated 
with vehicle revealed that fewer A20-deficient iNKT cells 
were detected in the spleen and liver when compared with 
those injected with wild-type iNKT cells (Fig. 3, H and I), 
and that chimeras treated with Z-VAD contained a signifi-
cantly higher frequency of A20-deficient iNKT cells than 
did chimeras treated with necrostatin 1 (Fig. 3, H and I). We 
Figure 2. iNKT cell development is regulated by A20. (A and B) Frequency and absolute iNKT cell counts in thymus (Thy), blood (Bld), spleen (Spl), liver 
(Lvr), lung (Lng), and PLN of control (n = 8) and CD4-cre;A20F/F (n = 9) mice, respectively. Data are from four independent experiments pooled. (C and D) 
Frequency and absolute cell counts of ST0, ST1, ST2, and ST3 iNKT cells isolated from thymi of control (n = 8) and CD4-cre;A20F/F (n = 9) mice, respectively. 
Data are pooled from two independent experiments. (E) Flow cytometric analysis and absolute cell counts (F) of NKT1a, NKT1b, NKT2, and NKT17 sublineages 
present in thymus, blood, spleen, liver, lung, and PLN of control (n = 8) and CD4-cre;A20F/F (n = 9) mice, respectively. Data are from four independent exper-
iments pooled. *, P < 0.05; **, P < 0.005; ***, P < 0.0005.
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therefore conclude that A20 functions to regulate cytokine 
production by NKT1 and NKT2 sublineages in a TCR-de-
pendent manner and limits AICD by apoptosis during devel-
opment and maturation in the peripheral compartment. In 
contrast, we show a limited role for A20 during development 
and survival of the NKT17 sublineage.
MALT1 threshold function regulates iNKT cell 
development in the absence of A20
Previous studies have demonstrated that recruitment of 
MALT1 to the CBM complex is essential for TCR-induced 
activation of NF-κB within the conventional T cell compart-
ment (Ruefli-Brasse et al., 2003; Kingeter and Schaefer, 2008). 
As a consequence, MALT1-deficient T cells exhibit impaired 
IL-2 production and diminished proliferation in response to 
TCR ligation. More recently, TCR ligation has been shown to 
induce the recruitment of A20 into a complex with MALT1 
and Bcl10 (Coornaert et al., 2008; Rebeaud et al., 2008), re-
sulting in MALT1-mediated cleavage of A20 and the induc-
tion of NF-κB. Thus, negative regulation of NF-κB in T cells 
also requires the proteolytic activity of MALT1 (Coornaert et 
al., 2008; Staal et al., 2011). Due to the central role of MALT1 
during TCR signaling, we sought to determine whether a 
MALT1-dependent threshold was required during iNKT cell 
development and activation in CD4-cre;A20F/F mice (Figs. 2 
and 3). Primary characterization showed no stringent require-
Figure 3. A20 regulates NKT1 and NKT2 sublineage activation and survival. qPCR analysis of A20 mRNA expression in bulk splenic iNKT (A) or 
NKT sublineage (B) cells after 24 h in vitro treatment with the indicated agents. Data are from two independent experiments. (C and D) CD69 and CXCR3 
expression on NKT1a, NKT1b, NKT2, and NKT17 cells isolated from thymi of control (n = 6) and CD4-cre;A20F/F mice (n = 6), respectively. Data are from two 
independent experiments. (E and F) α-CD3/CD28-induced cytokine production by in vitro–expanded control and A20-deficient NKT1 and NKT2 thymocytes 
(n = 3). Data are from two independent experiments. (G) FACS analysis of caspase 3 activity in NKT1, 2, and 17 sublineages isolated from thymus and spleen 
of control (n = 9) and CD4-cre;A20F/F (n = 9) mice, respectively. Data are pooled from three independent experiments. (H and I) Frequency of control and 
A20-deficient iNKT cells recovered from CD45.1 congenic mice after in vivo treatment with vehicle (control, n = 16; CD4-cre;A20F/F, n = 17), Z-VAD (10 mg/
kg; CD4-cre;A20F/F, n = 8), or Necrostatin-1 (10 mg/kg; CD4-cre;A20F/F, n = 7), respectively. FACS dot blots show CD45.2+ iNKT cells isolated from chimeras 
and represents pooled data from two independent experiments. *, P < 0.05; **, P < 0.005; ***, P < 0.0005. n.s., not significant.
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ment for MALT1 during iNKT cell development, as iNKT 
cell frequencies and absolute cell counts were comparable 
in thymus, spleen, and liver of germline MALT1-deficient 
(MALT1−/−) mice when compared with littermate controls 
(Fig. 4, A and B). Furthermore, MALT1-deficient and con-
trol iNKT cells produced equivalent levels of IL-4 after i.p. 
administration of α-Galactosylceramide (α-GalCer; Fig. 4 C), 
and transfer of MALT1-deficient iNKT thymocytes into ir-
radiated congenic hosts revealed no significant differences in 
survival (Fig.  4, D and E) or proliferation (Fig.  4 F) when 
compared with control iNKT cells. These results therefore 
show that in iNKT cells that express A20, TCR-induced cy-
tokine production and homeostasis of the iNKT cell lineage 
is not significantly altered by the absence of MALT1. To in-
vestigate MALT1 function during iNKT cell development 
in the absence of A20, we subsequently backcrossed CD4-
cre;A20F/F mice onto a MALT1-deficient background. Strik-
ingly, germline deletion of MALT1 in CD4-cre;A20F/F mice 
(CD4-cre;A20F/F;MALT1−/−) significantly restored iNKT 
cell development in the thymus, spleen, and liver when com-
pared with CD4-cre;A20F/F;MALT1+/− control mice (Fig. 4, 
A and B). Furthermore, complete rescue of NKT1 and NKT2 
sublineage development in the absence of A20 was achieved 
when MALT1 was conditionally deleted within iNKT cells 
using CD4-cre;A20F/F;MALT1F/F mice (Fig.  4, G–I). Thus, 
NKT sublineage differentiation and survival are regulated by 
a threshold function of MALT1 in the absence of A20.
To summarize, we define a regulatory role for A20 
during differentiation and survival of NKT sublineages in 
mouse. Here, A20 functions to limit TCR-dependent activa-
tion of the NKT1 and NKT2 sublineages in thymus, thereby 
preventing AICD after stimulation of the TCR. Furthermore, 
we show that both A20 and MALT1 dually regulate NKT 
sublineage differentiation and survival in a cell-intrinsic man-
ner. Our results therefore suggest that MALT1 may exert 
distinct threshold and/or modulatory functions in conjunc-
tion with A20 during iNKT cell development. Our findings 
also highlight that therapeutic inhibition of A20 within the 
iNKT cell compartment may have substantial clinical po-
tential in modulating or limiting iNKT cell activation or 
survival in defined inflammatory and autoimmune diseases 
(Kumar and Delovitch, 2014).
MAT ERI ALS AND MET HODS
Transgenic mice
To generate A20 (tnfaip3)EGFP reporter mice on a C57BL/6J 
background, a BAC containing the entire genomic locus of 
mouse tnfaip3, RP23-453B18, was ordered from the BAC 
PAC Resource Center (Oakland, CA). A cassette containing 
EGFP-stop-FRT-pgk/gb2-neo/kan-FRT was inserted in 
the ATG of exon 2 of tnfaip3 by Red/ET recombination. 
Subsequently, the selection cassette FRT-pgk/gb2-neo/kan-
FRT was removed by Flpe recombination in E. coli, result-
ing in a reporter construct where EGFP expression is driven 
by the tnfaip3 promoter. A 193-kb NruI-digested BAC frag-
ment was isolated by PFGE and injected into the pronuclei of 
C57BL/6J zygotes. Offspring was genotyped by PCR using 
primers specific for the EGFP transgene. To generate mice 
with a conditional MALT1 allele, Malt1tm1a(EUC OMM)Hmgu ES 
cells (129P2/OlaHsd) were ordered from IMPC, injected 
into 3.5-d blastocysts, and transferred to the uteri of pseu-
dopregnant foster mothers. Male chimeras were mated with 
C57BL/6 females to obtain germline transmission of the 
MALT1-floxed allele containing the neomycine selection 
cassette (MALT1NFL). The Frt-flanked neomycin cassette 
was removed by crossing MALT1NFL mice with an Flp-de-
leter strain (Rodríguez et al., 2000), generating a MALT1-
floxed allele (MALT1F/F). T cell–specific MALT1-deficient 
(CD4-cre;MALT1F/F) and A20-deficient (CD4-cre;A20F/F) 
mice were generated by intercrossing with C57BL/6 CD4-
cre transgenic mice for 5 and >10 generations, respectively. 
Germline MALT1−/− mice on a sv129 background were 
provided by T. Mak (Princess Margaret Cancer Centre, 
Ontario, Canada) and have been backcrossed to C57BL/6 
for >10 generations. Congenic B6.SJL-PtprcaPep3b/BoyJ 
breeders were purchased from Jackson ImmunoResearch 
Laboratories. All animal procedures were approved by the 
Institutional Animal Care and Ethics Committee.
Flow cytometry and antibodies
Cells were analyzed on FAC SCantoII (BD) and FlowJo soft-
ware (Tree Star), and sorted on FACS Aria II (BD). Antibodies 
used were CD122 PerCP-eFluor 710 (TM-b1), CD19-Per-
CP-Cy5.5 (eBio1D3), CD24-FITC (M1/69), CD25-PE 
(PC61.5), CD27-APC (LG.7F9), CD3ε-V500 (500A2), CD4-
APC-eFluor 780 (RM4-5), CD44-FITC/APC/APC-eFluor 
780 (IM7), CD45.1-PerCP-Cy5.5 (A20), CD45.2-APC-Cy7 
(104), NK1.1-PE-Cy7/PerCP-Cy5.5 (PK136), CD62L-
FITC/APC/PE-Cy7 (MEL-14), CD69-PE-Cy7 (H1.2F3), 
CD8α-APC (53–6.7), βTCR-APC-eFluor 780 (H57-597), 
Qa-2 FITC (69H1-9-9), and γδTCR PerCP-eFluor 710 
(eBioGL3; all from eBioscience). iNKT cells were stained at 
room temperature using α-GalCer–loaded CD1d tetramers. 
Stainings for intracellular antigens were performed using the 
FoxP3/Transcription Factor staining buffer set (eBioscience). 
Active caspase-3+ iNKT cells were stained using PhiPhiLux 
G1D2 (Oncoimmunin) according to the manufacturer’s rec-
ommendations. Subsets are defined as DN1 (CD25−CD44+); 
DN2 (CD25+CD44+); DN3 (CD25+CD44−); DN4 
(CD25−CD44−); ISP (CD25−CD44−CD3ε−CD4−CD8+); 
DP (CD4+CD8+); ST1 (CD44−NK1.1−); ST2 (CD44hi 
NK1.1−); ST3 (CD44hiNK1.1+); CD4naive (CD4+CD62Lhi 
CD44−); CD4memory (CD4+CD62L−CD44hi); iNKT (TCRβ+ 
CD1d-αGC+); NKT1a (CD27+IL-2Rβ+); NKT1b (CD27− 
IL-2Rβ+); NKT2 (CD27+IL-2Rβ−); NKT17 (CD27− 
IL-2Rβ−); and γδ (γδTCR+).
Cell suspension preparations
Single-cell suspensions from the thymus were resuspended 
in PBS containing 1 mM EDTA and 0.5% BSA, whereas 
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spleen and liver suspensions were layered over Ficoll or 33% 
Percoll gradients, respectively. Peripheral blood mononuclear 
cells were isolated by cardiac puncture in 20 U/ml PBS/
heparin and layered over a Ficoll gradient. iNKT thymocytes 
were enriched for using mouse CD8-Dynabeads (Invitro-
gen). Bone marrow mononuclear cells were flushed from the 
femur and tibia of mice and resuspended in PBS containing 
1 mM EDTA and 0.5% BSA.
Quantitative real-time RT-PCR
Total RNA was extracted from lymphocytes isolated from 
the thymus, spleen, and liver using the miRNeasy Mini kit 
(QIA GEN) and analyzed using the Agilent 2100 Bioana-
lyzer and RNA 6000 LabChip kit (Agilent Technologies). 
cDNA was produced and amplified using the QuantiTect 
Whole Transcriptome kit (QIA GEN). A20 mRNA was de-
tected using the following primer pair: forward, 5′-TTC 
AGG GCC AGC TAG TAT CCT GGG-3′; reverse, 5′-ACC 
TGC TGG CAG GAA ACC CC-3′. PCR products were 
amplified with the Fast Start SYBR Green Master mix 
(Roche) and detected with a LightCycler 480 System 
(Roche). Samples were normalized using qBasePlus (Bioga-
zelle NV) against at least three of the following genes: 
Rpl13a, Eif4b, B2m, Actb, or Gapdh as described previously 
(Drennan et al., 2014).
In vitro expansion and stimulation of iNKT cells
iNKT cells were isolated and FACS sorted from the pooled 
livers of 5 C57BL/6J mice, as previously described (Govin-
darajan et al., 2015). In brief, iNKT cells were resuspended in 
Figure 4. MALT1 deficiency rescues iNKT cell development in CD4-cre;A20F/F mice. (A) Frequency and absolute iNKT cell counts (B) in thymus and 
liver of MALT1+/− (n = 13), MALT1−/− (n = 12), CD4-cre;A20F/F;MALT1+/− (n = 6), and CD4-cre;A20F/F;MALT1−/− (n = 7) mice, respectively. Data are pooled from 
four independent experiments. (C) Serum IL-4 concentration in MALT1+/− (n = 26) and MALT−/− (n = 20) mice after i.p. injection of α-GalCer. Results are 
pooled from two independent experiments. (D and E) Frequency of MALT1+/− (n = 4) and MALT1−/− (n = 4) iNKT cells recovered from CD45.1 congenic mice 
after transfer of CFSE-labeled CD8-depleted thymocytes. (F) Homeostatic proliferation of MALT1+/− and MALT1−/− iNKT cells in the livers of congenic mice 
8 d after transfer. Data are from two independent experiments pooled. (G–I) Frequency and absolute iNKT cell counts in thymus, spleen, and liver of control 
A20F/F;MALT1F/F (n = 6) and CD4-cre;A20F/F;MALT1F/F (n = 6) mice, respectively. FACS dot blots in H are gated on βTCR+CD1d-αGC+ iNKT cells from each organ. 
Data are pooled from three independent experiments.*, P < 0.05; **, P < 0.01. n.s., not significant.
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complete RPMI-1640 medium containing 10 ng/ml recom-
binant mouse IL-2, 1 ng/ml recombinant mouse IL-12, and 
1 µg/ml soluble anti-CD28 (all from eBioscience) and plated 
in α-CD3ε–coated (3 µg/ml) 96-well flat-bottom plates at 
0.106 cells/well (BD). 2 d later, cells were rested for 2 d in 
complete RPMI-1640 medium, resuspended, and plated in 
complete RPMI-1640 medium containing 2 U/ml recombi-
nant mouse IL-7 (eBioscience) until day 8. iNKT cells were 
then resuspended in complete RPMI-1640 and cultured in 
α-CD3ε–coated 96-well plates until day 11. The latter two 
culture steps were repeated and, after 20–21 d, fully expanded 
iNKT cells were used for experiments. For restimulation ex-
periments, 105 iNKT cells were resuspended in RPMI-1640 
medium containing 10% heat inactivated FCS, 100 U/ml 
penicillin/streptomycin, 2 mM glutamine, 0.1 mM nonessen-
tial amino acids, 5.5 × 102 µM µ-ME (all from GIB CO), and 
stimulated with either α-CD3ε/CD28 (3 µg.ml−1/5 µg.ml−1), 
α-GalCer/CD1d (10 µg/ml−1/100 ng.ml−1), IL-1β (20 ng/
ml), IL-4 (20 ng/ml), IL-12p70 (20 ng/ml), IL-15 (20 ng/ml), 
IL-21 (20 ng/ml), IFN-β (100 U/ml), IP-10 (100 ng/ml), or 
LPS (20 ng/ml) for 24 h, after which cells were lysed and 
mRNA was isolated. Alternatively, 105 expanded NKT cell 
sublineage cells were restimulated with α-GalCer/CD1d (10 
µg/ml−1/100 ng.ml−1) for 72 h, after which supernatants were 
collected and used for cytokine measurements by ELI SA.
In vivo stimulation of iNKT cells
For serum IL-4 production, 5 µg of α-GalCer in 200ml PBS was 
injected i.p. Blood was subsequently collected after 4 h by ret-
roorbital puncture and assayed for cytokine content by ELI SA.
Generation of chimeras and transfer of 
CFSE-labeled thymocytes
Thymocytes isolated from MALT1+/− and MALT1−/− mice were 
depleted of CD8+cells using mouse CD8 Dynabeads (Invitro-
gen) and labeled with 3 µM CFSE (Molecular Probes). 1.5 × 
107 CFSE-labeled thymocytes were subsequently transferred i.v. 
into irradiated (300 rad) 8-wk-old CD45.1+ host animals. Alter-
natively, animals treated with the pancaspase inhibitor Z-VAD-
FMK (InvivoGen) or the necrosis inhibitor Necrostatin-1 
(Sigma-Aldrich), 1.3 × 107 CD8-depleted thymocytes from 
A20F/F or CD4-cre;A20F/F mice were transferred i.v. into irra-
diated (300 rad) 12-wk-old congenic (CD45.1) host animals pre-
treated with either vehicle (DMSO in PBS), Z-VAD-FMK (10 
mg/kg; InvivoGen) or Necrostatin-1 (10 mg/kg; Sigma-Aldrich) 
30 min before thymocyte transfer. Intraperitoneal injections of 
vehicle, Z-VAD-FMK, or Necrostatin-1 were subsequently con-
tinued every 16 h for the following 6 d. Single-cell suspensions of 
spleen and liver were subsequently stained with FACS antibodies 
and analyzed by flow cytometry.
Statistical analysis
Unless stated otherwise, mean data are expressed as means ± 
1 SD. P-values were calculated using the unpaired Student’s t 
test, and P < 0.05 was considered significant.
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